Leading drugmaker Sun Pharma is doubling down on its specialty portfolio, launching new products and ramping up ...

Revenue climbed 8.6% to Rs 14,405.2 crore, driven by double-digit growth in India, emerging markets, and rest of world (RoW) ...

So, if you're able to regularly invest in the Vanguard fund for many years, history offers us reason to be optimistic about ...

Investors seeking momentum may have iShares U.S. Pharmaceuticals ETF IHE on radar now. The fund recently hit a new 52-week high. Shares of IHE are up approximately 29.6% from their 52-week low of $58.

A new West Coast biotech has emerged into the busy in vivo cell therapy space, this time with the backing of Nobel Prize-winning CRISPR pioneer Jennifer Doudna, Ph.D. Azalea Therapeutics has bloomed ...

iShares Biotechnology ETF (IBB) offers targeted exposure to the U.S. biotechnology sector, providing investors with access to a broad basket of industry-leading biotech equities. The fund's strategy ...

Terns Pharmaceuticals Inc. (NASDAQ:TERN) stock is trading higher on Monday, with a session volume of 24.36 million, compared to its average volume of 1.31 million, according to Benzinga Pro. The ...

Harvest Lane Asset Management has implored the Treasurer to reconsider, saying it has “precarious implications that extend far beyond this transaction”.

A new partnership led by Memphis Mayor Paul Young aims to help Memphians impacted by the lapse in SNAP funding.

News archive including articles on Fund Managers, Fund Selection, Asset Allocation, Absolute Return, Offshore Investments, ...